HAV Hepatities A Virus IgG/IgM Test Cassette

HAV Hepatities A Virus IgG/IgM Test Cassette Overview

The HAV Hepatitis A Virus IgG/IgM Test Cassette is a rapid diagnostic lateral flow immunoassay used to qualitatively detect antibodies against the Hepatitis A Virus (HAV) in human whole blood, serum, or plasma. This point-of-care test is designed to differentiate between recent or current infections (IgM antibodies) and past infections indicating immunity (IgG antibodies). It serves as an essential screening tool for clinicians diagnosing symptomatic patients or evaluating immune status in high-risk populations in Bangladesh.

HAV Hepatities A Virus IgG/IgM Test Cassette Key Features

• Rapid Differential Diagnosis: Delivers clear results within 10 to 15 minutes, allowing for immediate clinical decision-making regarding patient isolation or vaccination history.
• High Specificity & Sensitivity: Utilizes advanced lateral flow immunoassay technology to accurately identify both IgG (past infection/immunity) and IgM (acute/recent infection) markers.
• Multi-Format Compatibility: Designed for versatility in medical settings, compatible with Whole Blood, Serum, and Plasma samples.
• Point-of-Care Ready: User-friendly cassette format requires minimal equipment, making it ideal for clinics, field hospitals, and mobile diagnostic units.
• Room Temperature Storage: Stable and reliable with storage requirements typically between 2-30°C, ensuring ease of logistics and inventory management.

Technical Specifications

• Methodology: Lateral Flow Immunoassay (Qualitative)
• Target Analytes: Anti-HAV IgG and Anti-HAV IgM antibodies
• Sample Type: Human Whole Blood, Serum, or Plasma
• Test Time: Results readable within 10–15 minutes
• Storage Conditions: 2°C to 30°C (Room Temperature)
• Reading: Visual Interpretation (Colored lines appear for positive results)
• Intended Use: Professional In-Vitro Diagnostic Use Only